首页> 外文期刊>Chemometrics and Intelligent Laboratory Systems >Multivariate evaluation of the effect of the particle size distribution of an Active Pharmaceutical Ingredient on the performance of a pharmaceutical drug product: a real-case study
【24h】

Multivariate evaluation of the effect of the particle size distribution of an Active Pharmaceutical Ingredient on the performance of a pharmaceutical drug product: a real-case study

机译:多变量评价活性药物成分对药物药品性能的粒度分布的影响:实际研究

获取原文
获取原文并翻译 | 示例
           

摘要

In the pharmaceutical field, and in particular for inhalation drug products based on Dry Powder Inhaler, the Active Pharmaceutical Ingredient particle size distribution is one of the key parameters to drive the final drug product performance. In this paper the impact of the Active Pharmaceutical Ingredient particle size on the Aerodynamic Particle Size Distribution of the final drug product was evaluated by applying different multivariate approaches. By using both the commonly employed particle size distribution descriptors (D10, D50, D90 and SPAN) and the whole particle size distribution curves it has been demonstrated that the latter gives an information which is easier to understand and interpret.
机译:在药物领域,特别是对于基于干粉吸入器的吸入药物产品,活性药物成分粒度分布是推动最终药物产品性能的关键参数之一。 本文通过施加不同的多变量方法,评价活性药物成分粒度对最终药物产品的空气动力学粒度分布的影响。 通过使用常用的粒度分布描述符(D10,D50,D90和跨度)和整个粒度分布曲线已经证明,后者给出了更容易理解和解释的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号